Ningbo Menovo Pharmaceutical Co., Ltd. Class ASSE: 603538

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 24, 2026 · Issued by Ningbo Menovo Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Ningbo Menovo Pharmaceutical Co., Ltd. Class A

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on the Dilution of Immediate Returns, Measures to Mitigate Such Dilution and the Undertakings by Relevant Parties in Relation to the 2026 Private Placement of A-Shares (Revised Draft)Sep 22
"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Completion of the Industrial and Commercial Registration Change and Issuance of a New Business LicenseSep 9
"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Sep 4
"Ningbo Menovo Pharmaceutical Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026Aug 19

All Ningbo Menovo Pharmaceutical Co., Ltd. Class A news releases